renal tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. patient who is doubt with renal tumor; 2. no age and gender restricted; 3. patient who signs the informed consents voluntarily; 4. patient without contraindications of CT and/ or MRI examination;
Exclusion criteria
Exclusion criteria: exclusion of CT examination 1. patient who is allergic to any component of Iodine contrast agents; 2. patient with hyperthyroidism or malignant thyroid tumor; 3. Patient with severe damage of renal function, defined as GFR<30mL/min1.73m2; 4. Pregnant or maybe pregnant woman; 5. Patient without good consciousness who may not complete the examination; 6. Patient with serious heart failure(NYHA 3-4); Patient with pacemaker, heart valve or other implants which cannot approach strong magnetic field; 7. patient with other X-ray examination within 72 hours to 7days before the contrast enhanced CT examination; 8. patient with other clinical trial within 30 days before the contrast enhanced CT examination; Exclusion of MRI examination 1.patient who is allergic to any component of Gadolinium contrast agents(if patient agree to take the contrast enhanced MR examination); 2. Patient with severe damage of renal function, defined as GFR<30mL/min1.73m2; 3. Patient with pacemaker, aneurysm clip or other implants which cannot approach strong magnetic field; 4. Pregnant or maybe pregnant woman; 5. Patient without good consciousness who may not complete the examination; 6. patient with Claustrophobia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| stage of malignant tumor;CT findings of tumor;fMRI findings fo tumor;Pathological benign or malignant;MR findings of tumor;subtype of malignant tumor;grade of malignant tumor; | — |
Countries
China